all AI news
XtalPi Announces Collaboration with Lilly
AI – AI-TechPark ai-techpark.com
Today, XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Company. The collaboration will leverage XtalPi’s integrated AI capabilities and robotics platform to de novo design and...
The post XtalPi Announces Collaboration with Lilly first appeared on AI-TechPark.
ai capabilities artificial artificial intelligence automation collaboration design discovery drug discovery intelligence payments pharmaceutical platform robotics technology xtalpi